Hypertension — Diagnosis And Treatment

  • Philip R. Liebson
  • Henry R. Black
Part of the Developments in Cardiovascular Medicine book series (DICM, volume 216)

Abstract

The appropriate utilization of resources in the diagnosis and treatment of hypertension may appear deceptively easy - establish that the blood pressure is elevated, and treat it with nutritional-hygienic intervention augmented, if necessary, by appropriate antihypertensive therapy, and bolstered by very few laboratory examinations such as serum electrolytes, glucose, creatinine, an electrocardiogram, and rarely an echocardiogram. The establishment of periodic guidelines, most recently the Joint National Committee (JNC) VI guidelines, provides a framework which can be easily utilized by the physician caring for a broad range of patients with hypertension(1,2)

Keywords

Caffeine Digoxin Triglyceride Theophylline Hyperaldosteronism 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Guidelines for the treatment of mild hypertension. Memorandum from a WHO/ISH meeting. J Hypertens 1992;11:905–918.Google Scholar
  2. 2.
    The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Int Med 1997; 157: 2412–2445.Google Scholar
  3. 3.
    Pickering T, for an American Society of Hypertension ad hoc panel. Recommendations for the use of home (self) and ambulatory blood pressure monitoring. Am J Hypertens 1995; 9: 1–11.CrossRefGoogle Scholar
  4. 4.
    Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Int Med 1991;114:345–352.PubMedGoogle Scholar
  5. 5.
    Black HR, Weltin G, Jaffe CC. The limited echocardiogram: a modification of standard echocardiography for use in routine evaluation of patients with systemic hypertension. Am J Cardiol 1991:67:1027–1030.PubMedCrossRefGoogle Scholar
  6. 6.
    Levy D, Garrison RJ, Savage DD et al. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study NEngl J Med 1990:322–1561–1566.Google Scholar
  7. 7.
    Schmieder RE, Martus P, Klingbeil A. Reversal of left ventricular hypertrophy in essential hypertension: a meta-analysis of randomized double-blind studies. JAMA 1996;275: 1507–1513.PubMedCrossRefGoogle Scholar
  8. 8.
    Materson BJ, Reda DJ, Cushman WC, et al, for the Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. Single-drug therapy for hypertension in men: a comparison of six antihypertensive agents with placebo. N Engl J Med 1993;328:914–921.PubMedCrossRefGoogle Scholar
  9. 9.
    Neaton JD, Grimm RH Jr, Prineas RJ, et al, for the Treatment of Mild Hypertension Study Research Group. Treatment ofMild Hypertension Study: final results. JAMA 1993;270;713–724.PubMedCrossRefGoogle Scholar
  10. 10.
    Liebson PR, Grandits GA, Dianzumba S, et al, for the Treatment of Mild Hypertension Study Research Group. Comparison of five antihypertensive monotherapies and placebo for change in left ventricular mass in patients receivibng nutritional-hygienic therapy inthe Treatment of Mild Hypertension Study (TOMHS). Circulation 1995;91:698–706.PubMedCrossRefGoogle Scholar
  11. 11.
    Mahoney LT, Schieken RM, Clarke WE, Lauer RM. Left ventricular mass and exercise responses predict future blood pressure. The Muscatine Study. Hypertension 1988;12:206–213.PubMedCrossRefGoogle Scholar
  12. 12.
    Devereux RB. Does increased blood pressure cause left ventricular hypertrophy and vice versa? Ann Int Med 1990;112:157–159.PubMedGoogle Scholar
  13. 13.
    Collins R, Peto R, Mac Mahon S, et al. Blood pressure, stroke, and coronary heart disease. Part vn2: short-term reductions in blood pressure: overview of randomized drug trials in their epidemiological context. Lancet 1990;335:827–838.PubMedCrossRefGoogle Scholar
  14. 14.
    Black HR, Yi J-Y. A new classification scheme for hypertension based on relative and absolute risk with implications for treatment and reimbursement. Hypertension 1996;28: 719–724.PubMedCrossRefGoogle Scholar
  15. 15.
    Alderman, MH. Blood pressure management: individualized treatment based on absolute risk and the potential of benefit. Ann Int Med 1993;119:329–335.PubMedGoogle Scholar
  16. 16.
    Hansson L, Zanchetti A, Carruthers SG, et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Primary results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet 1998;351:1755–1763.PubMedCrossRefGoogle Scholar
  17. 17.
    Moser M. Can the cost of care be contained and quality of care maintained in the management of hypertension? Arch Int Med 1994;154:1665–1672.CrossRefGoogle Scholar
  18. 18.
    Sibai BM. Treatment of hypertension in pregnant women. N Engl J Med 1996;335: 257–265.PubMedCrossRefGoogle Scholar
  19. 19.
    Systolic Hypertension in the Elderly Program Cooperative Research Group. Implications of the Systolic Hypertension in the Elderly program. Hypertension 1993;21:335–343.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1999

Authors and Affiliations

  • Philip R. Liebson
    • 1
  • Henry R. Black
    • 1
  1. 1.Rush-Presbyterian-St. Luke’s Medical CenterChicagoUSA

Personalised recommendations